HBK INVESTMENTS L P - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 217 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.

Quarter-by-quarter ownership
HBK INVESTMENTS L P ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$6,358,000
+14.9%
117,680
+19.5%
0.04%
+14.3%
Q2 2017$5,533,000
+359.9%
98,500
+93.2%
0.04%
+288.9%
Q2 2016$1,203,000
-30.0%
50,994
-39.4%
0.01%
-47.1%
Q1 2016$1,718,000
-33.1%
84,210
+68.8%
0.02%
-29.2%
Q4 2015$2,567,000
+283.7%
49,900
+217.8%
0.02%
+242.9%
Q3 2015$669,000
+109.7%
15,700
+124.3%
0.01%
+133.3%
Q2 2015$319,000
-78.1%
7,000
-81.7%
0.00%
-78.6%
Q1 2015$1,455,000
+161.2%
38,319
+100.6%
0.01%
+27.3%
Q2 2014$557,00019,1000.01%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 232,952$5,498,0005.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,673,727$86,700,0003.41%
Redmile Group, LLC 1,466,537$34,610,0003.31%
SECTORAL ASSET MANAGEMENT INC 1,229,382$29,013,0003.00%
HARVEY CAPITAL MANAGEMENT INC 206,530$4,874,0002.44%
Marcus Capital, LLC 75,150$1,774,0001.87%
Cormorant Asset Management, LP 396,000$9,346,0001.32%
Rail-Splitter Capital Management, LLC 221,414$5,225,0001.25%
Temasek Holdings (Private) Ltd 6,583,568$155,372,0001.21%
EMERALD MUTUAL FUND ADVISERS TRUST 636,526$15,022,0000.84%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders